SULLIVAN WAY SURGERY
SULLIVAN WAY, SCHOLES, WIGAN
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 18 | 22 | 81.8% | |
| CKD 4 | 2008 | 39 | 49 | 79.6% | |
| CKD 5 | 2009 | 29 | 31 | 93.5% | |
| CKD 5 | 2010 | 15 | 17 | 88.2% | |
| CKD 5 | 2011 | 20 | 21 | 95.2% | |
| CKD 5 | 2012 | 24 | 25 | 96.0% | |
| CKD 5 | 2013 | 24 | 27 | 88.9% | |
| CKD003 | 2014 | 23 | 26 | 88.5% | |
| CKD003 | 2015 | 21 | 23 | 91.3% | |
| NM84 | 2016 | 22 | 30 | 73.3% | |
| NM84 | 2017 | 27 | 34 | 79.4% | |
| NM84 | 2018 | 24 | 32 | 75.0% | |
| NM84 | 2019 | 27 | 35 | 77.1% | |
| NM84 | 2020 | 28 | 38 | 73.7% | |
| NM84 | 2022 | 24 | 33 | 72.7% | |
| NM84 | 2023 | 24 | 36 | 66.7% |
